Clinical Trial Update: Effect of GLP - 1 (7-36 Amide) on Myocardial Function Following Coronary Artery Bypass (CABG) Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of GLP-1 (7-36) amide on myocardial function after coronary artery bypass grafting; the study was terminated and results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• GLP-1 (7-36) Amide (glucagon-like peptide-1 (7-36) amide)

Snippet

Sponsor: Johns Hopkins University | Conditions: CABG | Phase 2 | Status: TERMINATED | Results posted: 2017-07-12